Inaktiver Wert

Andere Sprachen EXOPHARM

Aktien

A3DHYL

AU0000030975

EX1

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Tryp Therapeutics Inc. completed the acquisition of Exopharm Limited in a reverse merger transaction.	01.05.
Exopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26.02.
Exopharm to Cut CEO Role Amid Cost Reductions	28.11.
Exopharm Limited Announces Ian Dixon's Employment as CEO Expects to End in Early Calendar Year 2024	27.11.
Exopharm Limited Reports Earnings Results for the Full Year Ended June 30, 2023	29.08.23
Exopharm Limited Announces Executive Changes	22.06.23
Exopharm Achieves Initial Success With Exosome Products; Shares Fall 21%	28.04.23
Exopharm Secures R&D Cash Loan Advance from Radium Capital	09.03.23
Exopharm Limited announced that it has received AUD 1 million in funding	09.03.23
Exopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2022	26.02.23
Exopharm Limited Announces Board Changes	22.02.23
Exopharm Limited announced that it expects to receive AUD 0.6 million in funding	13.02.23
Exopharm Limited Announces Resignation of Elizabeth McGregor as Non-Executive Director	20.12.22
Sartorius BIA Separations and Exopharm Ltd Testing the Synergy of Exopharm's Patented LEAP Technology Together with Bia's Unique Cim (Convective Interaction Media) Monolith Chromatography for Improved Large- Scale Exosome Production and Commercialization	16.11.22
Exopharm Limited Will Commence LEAP Technology Transfer to AIRM under MSA	13.11.22
Exopharm Receives $2.6 Million R&D Tax Rebate	27.10.22
Exopharm Says Drug Product Safe After Animal Testing	28.09.22
Exopharm Limited Announces Study Results Indicate Exosomes Safe for Clinical Pursuit	28.09.22
Exopharm Limited Reports Earnings Results for the Full Year Ended June 30, 2022	31.08.22
Exopharm Limited Auditor Raises 'Going Concern' Doubt	30.08.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen EXOPHARM

Aktien

A3DHYL

AU0000030975

EX1

Andere Sprachen

Filter